11-Methyl-13-(3-methylphenyl)-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8,10,12-hexaene-10-carbonitrile

Catalog No. :
ACOZAS962
CAS No. :
730976-50-8
Molecular Formula :
C20H15N3
Molecular Weight :
297.36

IUPAC Name:3-methyl-1-(m-tolyl)benzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile

11-Methyl-13-(3-methylphenyl)-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8,10,12-hexaene-10-carbonitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg95%$70.00Login to see priceInquiryInquiry
100mg95%$100.00Login to see priceInquiryInquiry
250mg95%$132.00Login to see priceInquiryInquiry
1g95%$337.00Login to see priceInquiryInquiry
5g95%$946.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name11-Methyl-13-(3-methylphenyl)-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8,10,12-hexaene-10-carbonitrile
IUPAC Name3-methyl-1-(m-tolyl)benzo[4,5]imidazo[1,2-a]pyridine-4-carbonitrile
MDL No.MFCD04623503
Molecular FormulaC20H15N3
Molecular Weight297.36
SMILESN#CC1=C(C)C=C(C2=CC=CC(C)=C2)N3C4=CC=CC=C4N=C13
InChI KeyOXANCQIRPXSDBU-UHFFFAOYSA-N
Synonym11-methyl-13-(3-methylphenyl)-1,8-diazatricyclo[7.4.0.0,2,7]trideca-2,4,6,8,10,12-hexaene-10-carbonitrile;Pyrido[1,2-a]benzimidazole-4-carbonitrile, 3-methyl-1-(3-methylphenyl)-
CAS No.730976-50-8

Synthetic Route by SureRoute

1. ACOZAS962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACOZAS962 route product structure diagram
    ACOZAS962730976-50-8
Inquiry

2. ACOZAS962 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACEUNQ805 route compound structure diagram
    ACEUNQ80517933-03-8 In Stock
  4. Then
  5. ACOZAS962 route product structure diagram
    ACOZAS962730976-50-8
Inquiry

Comments (0)